Idarucizumab Reverses Dabigatran Regardless of Renal Function Idarucizumab Reverses Dabigatran Regardless of Renal Function

In a RE-VERSE AD subgroup analysis, idarucizumab reversed the effects of dabigatran in more than 98% of patients, regardless of renal function.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Cardiology News Source Type: news